DDInter1799 DDInter1082
Thyroid extract is dried and powdered thyroid glands from pigs containing tiiodothyronine (T3) and thyroxine (T4) used to supplement low or absent thyroid activity.[A190831,L11755] Thyroid extract has been described in literature to treat hypothyroidism since 1891 but its use dates back as far as the 6th century. Thyroid extract is no longer considered a first line therapy as it delivers a dose that is inconsistent with the stated strength of the tablet. Currently, patients are more likely to be treated with [levothyroxine]. Thyroid extracts were never FDA approved as their use in the United States predates the FDA.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Thyroid, porcine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Sucralfate
Thyroid, porcine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Miglitol
Thyroid, porcine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Iron sucrose
Thyroid, porcine may cause a minor interaction that can limit clinical effects when taken with Sucralfate
Thyroid, porcine may cause a moderate interaction that could exacerbate diseases when taken with Miglitol
Thyroid, porcine may cause a moderate interaction that could exacerbate diseases when taken with Iron sucrose